Stock VRPX VIRPAX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Virpax Pharmaceuticals, Inc.

Equities

VRPX

US9282512063

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.1 USD +6.22% Intraday chart for Virpax Pharmaceuticals, Inc. -15.76% -3.16%
Mar. 26 Virpax Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 15 Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs MT

Evolution of the average Target Price on Virpax Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

72717d15d11e241f0127b.lMbDQv4nmQ_fWTT2FrGJgNt-jCMaCZC64lX3v2DOs4A.pPPyCs5s1FecNlCddcPN068rvFtdSvTPtgXC9wmchcbCs7JvkGrwNrsRBA~94ca573fb702f73c998351fc6c0e9f32

Analyst Recommendations on Virpax Pharmaceuticals, Inc.

Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data RE
Maxim Group Initiates Coverage on Virpax Pharmaceuticals With Buy Rating, $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.1 USD
Average target price
20 USD
Spread / Average Target
+545.16%
High Price Target
20 USD
Spread / Highest target
+545.16%
Low Price Target
20 USD
Spread / Lowest Target
+545.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Virpax Pharmaceuticals, Inc.

Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VRPX Stock
  4. Consensus Virpax Pharmaceuticals, Inc.